Japan Weekly | Advantest, Nihon M&A, Sumi Pharm
Japan this week: Topix +1.3% at 2,266. Nikkei +0.2% at 31,624, USD/JPY +0.8% at 146.4. The notable loser this week was Advantest, following...
354 Views
Sekisui Chem (4204) | Potential of Perovskite PV
Perovskite solar cells have the potential to be more efficient and less expensive than traditional silicon solar cells. Sekisui Chemical is about...
497 Views
A Round up of Some Japanese Equities Buys as We Begin the New Year.
Please see some recent buy ideas, all very cheap, that we believe offer decent longer term growth and have had a dreadful December. We have written...
647 Views
Sekisui Chemical (4204) Near Term Weakness Is Opportunity to Buy
This is a good long term buy. Although first half results fell slightly short of expectations, this was largely due to an earthquake in Hokkaido as...
331 Views
Large-Cap Names that Have Gotten a Lot More Volatile Recently....
We screened for large-cap names in Japan that have recently seen a spike in volatility. We calculated Beta over the last 6 months and compared it...
275 Views